Literature DB >> 18963541

Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.

Sotirios Bisdas1, Shaun A Nguyen, Sharma K Anand, Gordana Glavina, Terry Day, Zoran Rumboldt.   

Abstract

PURPOSE: To assess whether pretreatment perfusion computed tomography (PCT) may predict outcome in chemoradiated patients with oral cavity, oropharynx, and hypopharynx squamous cell carcinoma (SCCA) after surgical excision.
MATERIALS AND METHODS: Twenty-one patients with SCCA were examined before treatment. The primary site was oral cavity in 6, oropharynx in 7, and hypopharynx in 8 patients; there were 11 T2, 6 T3, and 4 T4 tumors. PCT was performed at the level of largest tumor diameter based on standard neck CT. The data were processed to obtain blood flow (BF), blood volume (BV), mean transit time (MTT), and permeability surface area product (PS). Regions of interest were free-hand positioned on the lesions to obtain PCT measurements. Tumor volume was also calculated. Follow-up was performed with positron emission tomography (PET)/CT and endoscopy. Pearson correlation coefficient was used for comparison between the subgroups. A regression model was constructed to predict recurrence based on the following predictors: age, gender, tumor (T) and nodal (N) stage, tumor volume, and PCT parameters.
RESULTS: BF(mean), BF(max), BV(mean), BV(max), MTT(mean), PS(mean), and PS(max) were significantly different between patients with and without tumor recurrence (0.0001, p < 0.04). T stage, tumor volume, N stage, BF(max), BV(max), MTT(mean), and radiation dose (p < 0.001) were independent predictors for recurrence. Cox proportional hazards model for tumor recurrence revealed significantly increased risk with high tumor volume (p = 0.00001, relative risk [RR] 7.4), low PS(mean) (p = 0.0001, RR 14.3), and low BF(max) (p = 0.002, RR 5.9).
CONCLUSIONS: Our data suggest that PCT parameters have a prognostic role in patients with SCCA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18963541     DOI: 10.1016/j.ijrobp.2008.06.1956

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

Review 1.  Biologic imaging of head and neck cancer: the present and the future.

Authors:  A Srinivasan; S Mohan; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

2.  Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy.

Authors:  M T Truong; N Saito; A Ozonoff; J Wang; R Lee; M M Qureshi; S Jalisi; O Sakai
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

Review 3.  Imaging hypoxia to improve radiotherapy outcome.

Authors:  Michael R Horsman; Lise Saksø Mortensen; Jørgen B Petersen; Morten Busk; Jens Overgaard
Journal:  Nat Rev Clin Oncol       Date:  2012-11-13       Impact factor: 66.675

4.  Human papillomavirus, p16, and epidermal growth factor receptor biomarkers and CT perfusion values in head and neck squamous cell carcinoma.

Authors:  N L Hoefling; J B McHugh; E Light; B Kumar; H Walline; M Prince; C Bradford; T E Carey; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-31       Impact factor: 3.825

5.  Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements.

Authors:  S Bisdas; Z Rumboldt; K Surlan-Popovic; M Baghi; T S Koh; T J Vogl; M G Mack
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-29       Impact factor: 3.825

6.  Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy.

Authors:  K Surlan-Popovic; S Bisdas; Z Rumboldt; T S Koh; P Strojan
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-29       Impact factor: 3.825

7.  Establishment and characterization of patient tumor-derived head and neck squamous cell carcinoma xenografts.

Authors:  Mukund Seshadri; Mihai Merzianu; Haikuo Tang; Nestor R Rigual; Maureen Sullivan; Thom R Loree; Saurin R Popat; Elizabeth A Repasky; Bonnie L Hylander
Journal:  Cancer Biol Ther       Date:  2009-12-19       Impact factor: 4.742

8.  CT Texture Analysis Potentially Predicts Local Failure in Head and Neck Squamous Cell Carcinoma Treated with Chemoradiotherapy.

Authors:  H Kuno; M M Qureshi; M N Chapman; B Li; V C Andreu-Arasa; K Onoue; M T Truong; O Sakai
Journal:  AJNR Am J Neuroradiol       Date:  2017-10-12       Impact factor: 3.825

9.  Head and neck tumors: assessment of perfusion-related parameters and diffusion coefficients based on the intravoxel incoherent motion model.

Authors:  M Sumi; T Nakamura
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-02       Impact factor: 3.825

10.  Impact of lymph node ratio on the survival of patients with hypopharyngeal squamous cell carcinoma: a population-based analysis.

Authors:  Yu-Long Wang; Shou-Hao Feng; Ji Zhu; Guo-Pei Zhu; Duan-Shu Li; Yu Wang; Yong-Xue Zhu; Guo-Hua Sun; Qing-Hai Ji
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.